Medpage Today on MSN5d
Study Questions Need to Hold SGLT2 Inhibitors Before SurgeryPreoperative use of SGLT2 inhibitors among patients with type 2 diabetes undergoing emergency surgery was not associated with ...
If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.
Medpage Today on MSN5d
SGLT2 Inhibitors May Slow Nonsevere Aortic Stenosis ProgressionFor the first time, researchers said SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis ...
Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
Researchers have found in a new study that SGLT2 inhibitors may have disease-modifying effects in nonsevere aortic stenosis ...
The Role of Kidney in Glucose Homeostasis — SGLT2 Inhibitors, a New Approach in Diabetes Treatment
SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
A new study, authored by KBH Professor Jan Inge Henter and published in the New England Journal of Medicine, has investigated ...
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback